• Skip to main content
  • Skip to primary sidebar

  • Home
  • About
    • Overview
    • Owners and Intermediaries
    • Management Teams
    • Investors
  • Strategy
    • Overview
    • Disciplined Sector Focus
    • Long-Term Business Improvement
    • Investment Criteria & Transaction Profile
  • Sustainability
    • ESG Principles
    • Implementation
    • Core Areas
    • SK Portfolio EcoVadis Ratings
    • SKCP ESG Report
  • Portfolio
  • Team
  • News
  • Contact
  • Investor Login

Portfolio

/ June 7, 2021

Canlak

Canlak Coatings is a formulator and manufacturer of high-quality wood coatings systems for commercial and residential flooring, sports flooring, cabinet, furniture and architectural applications. The Company offers an expansive portfolio of coatings technologies, including UV-cured, waterborne, high-performance polyurethanes and traditional lacquers and varnishes. Canlak provides custom and standardized formulations for OEM and Refinish applicators, developed through a robust R&D and technical application department. Headquartered in North Brunswick, New Jersey, Canlak operates from four production facilities across the United States and Canada.

Canlak was formed through the acquisitions of Canlak Inc. and Valentus Specialty Chemicals in 2021. The newly combined company is marketed under the Canlak Coatings brand.

For more information on Canlak, please visit https://canlak.com/en/

 

 

 

 

 

Primary Sidebar

Related News

  • SK Capital Announces Acquisition of Canlak and Valentus Specialty Chemicals

    May 27, 2021

SK Capital Portfolio Companies

  • Florachem
  • Heubach
  • Seqens
  • Deltech LLC
  • Canlak
  • IPACKCHEM
  • Woodstock Sterile Solutions
  • Lacerta Group
  • Venator
  • Tilley
  • NuCera Solutions
  • Techmer PM
  • GEON
  • SI Group
  • Perimeter Solutions
  • Wavelength
  • Foremark
  • Tri-Tex
  • Niacet
  • Noramco
  • Extractas Bioscience
  • Purisys
  • Archroma
  • Addivant
  • TPC Group
  • Ascend
  • IBA Molecular
  • Calabrian Corporation
  • Halo Pharmaceutical
  • AEB Group

To request for a copy of our ESG report, please click here.

© 2022 SK Capital Partners. All Rights Reserved.

Important Disclosures

  • Home
  • About
    • Overview
    • Owners and Intermediaries
    • Management Teams
    • Investors
    • Back
  • Strategy
    • Overview
    • Disciplined Sector Focus
    • Long-Term Business Improvement
    • Investment Criteria & Transaction Profile
    • Back
  • Sustainability
    • ESG Principles
    • Implementation
    • Core Areas
    • SK Portfolio EcoVadis Ratings
    • SKCP ESG Report
    • Back
  • Portfolio
  • Team
  • News
  • Contact
  • Investor Login